[1] Wertz P W, de Szalay S. Innate antimicrobial defense of skin and oral mucosa[J]. Antibiotics, 2020,9(4):159. doi:10.3390/antibiotics9040159. [2] Di Y P. Antimicrobial peptides in host defense against drug-resistant bacterial and viral infections[J]. Curr Med Chem, 2020,27(9):1385-1386. doi:10.2174/092986732709200327085156. [3] Sierra J M, Fusté E, Rabanal F, Vinuesa T, Viñas M. An overview of antimicrobial peptides and the latest advances in their development[J]. Expert Opin Biol Ther, 2017,17(6):663-676. doi:10.1080/14712598.2017.1315402. [4] Sader H S, Fedler K A, Rennie R P, Stevens S, Jones R N. Omiganan pentahydrochloride (MBI 226), a topical 12-amino-acid cationic peptide:spectrum of antimicrobial activity and measurements of bactericidal activity[J]. Antimicrob Agents and Chemother, 2004,48(8):3112-3118. doi:10.1128/AAC.48.8.3112-3118.2004. [5] Rubinchik E, Dugourd D, Algara T, Pasetka C, Friedland H D. Antimicrobial and antifungal activities of a novel cationic antimicrobial peptide, omiganan, in experimental skin colonisation models[J]. Int J Antimicrob Agents, 2009,34(5):457-461. doi:10.1016/j.ijantimicag.2009.05.003. [6] Grievink H W, Jirka S M G, Woutman T D, Schoonakker M, Rissmann R, Malone K E, Feiss G, Moerland M. Antimicrobial peptide omiganan enhances interferon responses to endosomal toll-like receptor ligands in human peripheral blood mononuclear cells[J]. Clin Transl Sci, 2020,13(5):891-895. doi:10.1111/cts.12789. [7] Niemeyer-van der Kolk T, Assil S, Buters T P, Rijsbergen M, Klaassen E S, Feiss G, Florencia E, Prens E P, Burggraaf J, van Doorn M B A, Rissmann R, Moerland M. Omiganan enhances imiquimod-induced inflammatory responses in skin of healthy volunteers[J]. Clin Transl Sci, 2020,13(3):573-579. doi:10.1111/cts.12741. [8] Rijsbergen M, Rijneveld R, Todd M, Feiss G L, Kouwenhoven S T P, Quint K D, van Alewijk D C J G, de Koning M N C, Klaassen E S, Burggraaf J, Rissmann R, van Poelgeest M I E. Results of phase 2 trials exploring the safety and efficacy of omiganan in patients with human papillomavirus-induced genital lesions[J]. Br J Clin Pharmacol, 2020,86(11):2133-2143. doi:10.1111/bcp.14181. [9] Studier F W. Protein production by auto-induction in high density shaking cultures[J]. Protein Expr Purif, 2005,41(1):207-234. doi:10.1016/j.pep.2005.01.016. [10] Sabatier J M. Antibacterial peptides[J]. Antibiotics, 2020,9(4):142.doi:10.3390/antibiotics9040142. [11] Kang H K, Kim C, Seo C H, Park Y. The therapeutic applications of antimicrobial peptides (AMPs):a patent review[J]. J Microbiol, 2017,55(1):1-12. doi:10.1007/s12275-017-6452-1. [12] Haney E F, Mansour S C, Hancock R E W. Antimicrobial peptides:An introduction[J]. Methods Mol Biol, 2017,1548:3-22. doi:10.1007/978-1-4939-6737-7_1. [13] Ghosh C, Haldar D J. Membrane-active small molecules:designs inspired by antimicrobial peptides[J]. Chem Med Chem, 2015,10(10):1606-1624. doi:10.1002/cmdc.201500299. [14] Chen C H, Lu T K. Development and challenges of antimicrobial peptides for therapeutic applications[J]. Antibiotics (Basel),2020,9(1):24-30. doi:10.3390/antibiotics9010024. [15] Deslouches B, Di Y P. Antimicrobial peptides with selective antitumor mechanisms:prospect for anticancer applications[J]. Oncotarget, 2017,8(28):46635-46651.doi:10.18632/oncotarget. 16743. [16] Taniguchi M, Ochiai A, Takahashi K, Nakamichi S I, Nomoto T, Saitoh E, Kato T, Tanaka T. Antimicrobial activity against Porphyromonas gingivalis and mechanism of action of the cationic octadecapeptide AmyI-1-18 and its amino acid-substituted analogs[J]. J Biosci Bioeng, 2016,122(6):652-659. doi:10.1016/j.jbiosc.2016.05.008. [17] Garaicoa J L, Bates A M, Avila-Ortiz G, Brogden K A. Antimicrobial prosthetic surfaces in the oral Cavity-A perspective on creative approaches[J]. Microorganisms, 2020,8(8):1247-1260. doi:10.3390/microorganisms8081247. [18] Luong H X, Thanh T T, Tran T H. Antimicrobial peptides-Advances in development of therapeutic applications[J]. Life Sci, 2020, 260(11):15-21. doi:10.1016/j.lfs.2020.118407. [19] Aguilar-Toalá J E, Hernández-Mendoza A, González-Córdova A F, Vallejo-Cordoba B, Liceaga A M. Potential role of natural bioactive peptides for development of cosmeceutical skin products[J]. Peptides, 2019,122(12):80-91. doi:10.1016/j.peptides.2019.170170. [20] Abriani A, Hamad C. Activated antimicrobial peptides due to periodontal bacteria in synovial fluid-The link between psoriatic arthritis and periodontitis?[J]. Med Hypotheses, 2020,144(11):109967. doi:10.1016/j.mehy.2020.109967. [21] Enigk K, Jentsch H, Rodloff A C, Eschrich K, Stingu C S. Activity of five antimicrobial peptides against periodontal as well as non-periodontal pathogenic strains[J]. J Oral Microbiol, 2020,12(1):11-18. doi:10.1080/20002297.2020.1829405. |